PATENT CLAIM ANALYSIS

Application Number: 15960709
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["424", "400000"]

Abstract:
This disclosure provides pharmaceutical adenovirus formulations, in particular, liquid pharmaceutical formulations comprising adenoviruses.

Claim (Index 23):
The method of  claim 21 , wherein the salt is sodium chloride (NaCl), and the concentration of the NaCl is between about 20 mM and about 200 mM.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 91.0
- Lexical Diversity: 1.23077
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14916539', '11071095', '10791503', '14988138', '14208919']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7332324454324068
- 35 USC 102 Novelty (BERT): 0.6359476986031616
- Combined Prediction Score: 0.7235039707494824
- Mean Citation Score: 320.70632599999993
- Max Citation Score: 602.6609
- Similarity Product: 548.2603632977426

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test